Bernard F, Casanova J L, Cournot G, Jabado N, Peake J, Jauliac S, Fischer A, Hivroz C
Institut National de la Santé et de la Recherche Médicale U429, Paris, France.
J Pediatr. 1998 Oct;133(4):537-43. doi: 10.1016/s0022-3476(98)70064-2.
Osteopetrosis has been described in mice generated by homozygous gene disruption of c-src gene encoding for the p60c-Src protein tyrosine kinase (Src-/- mice). The similarities of bone histologic findings in this murine model to those observed in some patients first seen with autosomal recessive osteopetrosis, "malignant" osteopetrosis, led us to investigate the potential role of p60c-Src in the pathogenesis of malignant osteopetrosis in 13 children. In 4 patients a c-src mutation was ruled out by an intragenic microsatellite segregation study. In the other 9 we analyzed p60c-Src expression and function, as well as c-src sequence. The expression was normal in all of the patients tested. In addition, the tyrosine phosphorylation and kinase activity of p60c-Src were also normal in all of the patients. Moreover, in these patients, sequences of the coding region of c-src were identical to the published sequence of the human c-src complementary DNA. These results exclude a role for c-src in the pathogenesis of human malignant osteopetrosis in the 13 patients analyzed.
在通过编码p60c-Src蛋白酪氨酸激酶的c-src基因纯合子基因敲除产生的小鼠中已描述了骨硬化症(Src-/-小鼠)。该小鼠模型中的骨组织学发现与一些首次被诊断为常染色体隐性骨硬化症(“恶性”骨硬化症)的患者所观察到的相似,这促使我们研究p60c-Src在13名儿童恶性骨硬化症发病机制中的潜在作用。通过基因内微卫星分离研究排除了4例患者的c-src突变。在其他9例患者中,我们分析了p60c-Src的表达和功能以及c-src序列。所有测试患者的表达均正常。此外,所有患者中p60c-Src的酪氨酸磷酸化和激酶活性也均正常。此外,在这些患者中,c-src编码区的序列与已发表的人c-src互补DNA序列相同。这些结果排除了c-src在所分析的13例患者的人类恶性骨硬化症发病机制中的作用。